BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: DiMartini A, Cruz RJ Jr, Dew MA, Myaskovsky L, Goodpaster B, Fox K, Kim KH, Fontes P. Muscle mass predicts outcomes following liver transplantation. Liver Transpl 2013;19:1172-80. [PMID: 23960026 DOI: 10.1002/lt.23724] [Cited by in Crossref: 156] [Cited by in F6Publishing: 155] [Article Influence: 15.6] [Reference Citation Analysis]
Number Citing Articles
1 Huang Y, Wang N, Xu L, Wu Y, Li H, Jiang L, Xu M. Albumin–Globulin Score Combined with Skeletal Muscle Index as a Novel Prognostic Marker for Hepatocellular Carcinoma Patients Undergoing Liver Transplantation. JCM 2023;12:2237. [DOI: 10.3390/jcm12062237] [Reference Citation Analysis]
2 Kharawala A, Safiriyu I, Olayinka A, Hajra A, Seo J, Akunor H, Alhuarrat MA, Tachil R. Incidence, predictors and outcomes of new onset systolic heart failure following Orthotopic liver transplant: A systematic review. Transplantation Reviews 2023. [DOI: 10.1016/j.trre.2023.100758] [Reference Citation Analysis]
3 Shafaat O, Liu Y, Jackson KR, Motter JD, Boyarsky BJ, Latif MA, Yuan F, Khalil A, King EA, Zaheer A, Summers RM, Segev DL, McAdams-DeMarco M, Weiss CR. Association between Abdominal CT Measurements of Body Composition before Deceased Donor Liver Transplant with Posttransplant Outcomes. Radiology 2023;306:e212403. [PMID: 36283115 DOI: 10.1148/radiol.212403] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sim JH, Kim KW, Ko Y, Kwon HM, Moon YJ, Jun IG, Kim SH, Kim S, Song JG, Hwang GS. Association of sex-specific donor skeletal muscle index with surgical outcomes in living donor liver transplantation recipients. Liver Int 2023;43:684-94. [PMID: 36377561 DOI: 10.1111/liv.15478] [Reference Citation Analysis]
5 Casciola R, Leoni L, Cuffari B, Pecchini M, Menozzi R, Colecchia A, Ravaioli F. Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives. Nutrients 2023;15. [PMID: 36839220 DOI: 10.3390/nu15040863] [Reference Citation Analysis]
6 Wang C, Teng Y, Gao J, Zhang Z, Li Y. Low adipose tissue index as an indicator of hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt. Abdom Radiol (NY) 2023. [PMID: 36735033 DOI: 10.1007/s00261-023-03813-4] [Reference Citation Analysis]
7 Liu J, Yang C, Yao J, Bai Y, Li T, Wang Y, Shi Q, Wu X, Ma J, Zhou C, Huang S, Xiong B. Improvement of sarcopenia is beneficial for prognosis in cirrhotic patients after TIPS placement. Dig Liver Dis 2023:S1590-8658(23)00003-8. [PMID: 36682922 DOI: 10.1016/j.dld.2023.01.001] [Reference Citation Analysis]
8 Song DS, Chang UI, Yang JM. Letter regarding "Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis". Clin Mol Hepatol 2023;29:165-7. [PMID: 36314043 DOI: 10.3350/cmh.2022.0339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Plauth M. Nutrition in liver disease. Comprehensive Guide to Hepatitis Advances 2023. [DOI: 10.1016/b978-0-323-98368-6.00004-5] [Reference Citation Analysis]
10 Karakizlis H, Trudel N, Brose A, Reinisch A, Reichert M, Hecker A, Bender F, Askevold I, Rainer L, Weimer R, Krombach GA, Padberg W, Liese J. Sarcopenia of kidney transplant recipients as a predictive marker for reduced graft function and graft survival after kidney transplantation. Langenbecks Arch Surg 2023;408:103. [PMID: 36826595 DOI: 10.1007/s00423-023-02836-1] [Reference Citation Analysis]
11 Currie BM, Bakhtiar M, Nadolski GJ, Soulen MC. Mitigation of Sarcopenia after Peritoneovenous Shunt Placement in Patients with Refractory Ascites. J Vasc Interv Radiol 2022:S1051-0443(22)01443-9. [PMID: 36563934 DOI: 10.1016/j.jvir.2022.12.037] [Reference Citation Analysis]
12 Sano A, Inoue J, Kakazu E, Ninomiya M, Iwata T, Tsuruoka M, Sato K, Onuki M, Sawahashi S, Masamune A. Omega-3 polyunsaturated fatty acids are associated with sarcopenia in patients with liver cirrhosis and hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-2344312/v1] [Reference Citation Analysis]
13 Chen C, Ayers M, Squires JH, Squires JE. Perspectives on Sarcopenia as a Predictor for Outcomes in Pediatric Patients with Chronic Liver Disease. Hepat Med 2022;14:173-83. [PMID: 36320211 DOI: 10.2147/HMER.S348888] [Reference Citation Analysis]
14 Mehtani R, Premkumar M, Kulkarni AV. Nutrition in Critical Care Hepatology. Curr Hepatology Rep 2022. [DOI: 10.1007/s11901-022-00586-0] [Reference Citation Analysis]
15 Crespo G, Hessheimer AJ, Armstrong MJ, Berzigotti A, Monbaliu D, Spiro M, Raptis DA, Lai JC; ERAS4OLT.org Working Group. Which preoperative assessment modalities best identify patients who are suitable for enhanced recovery after liver transplantation? A systematic review of the literature and expert panel recommendations. Clin Transplant 2022;36:e14644. [PMID: 35293025 DOI: 10.1111/ctr.14644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Lovesley D, John S, Khakhar A, Ramakrishnan B, Ramamurthy A. Handgrip strength: A simple and effective tool to predict mortality after liver transplantation. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.08.006] [Reference Citation Analysis]
17 Gabbay U, Issachar A, Cohen-naftaly M, Brown M, Nesher E. Gender specific survival rates after deceased donor liver transplantation: A retrospective cohort. Annals of Medicine and Surgery 2022;79:103933. [DOI: 10.1016/j.amsu.2022.103933] [Reference Citation Analysis]
18 De A, Kumari S, Kaur A, Singh A, Kalra N, Singh V. Hand-grip strength as a screening tool for sarcopenia in males with decompensated cirrhosis. Indian J Gastroenterol 2022;41:284-91. [PMID: 35852763 DOI: 10.1007/s12664-022-01255-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Nappi C, Megna R, Volpe F, Ponsiglione A, Caiazzo E, Piscopo L, Mainolfi CG, Vergara E, Imbriaco M, Klain M, Petretta M, Cuocolo A. Quantification of Coronary Artery Atherosclerotic Burden and Muscle Mass: Exploratory Comparison of Two Freely Available Software Programs. Applied Sciences 2022;12:5468. [DOI: 10.3390/app12115468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Lee C, Wu M, Chan H, Chen T, Hsu L, Wu M, Cherng Y. The Influence of Diabetes Mellitus on the Risks of End-Stage Kidney Disease and Mortality After Liver Transplantation. Transpl Int 2022;36:10023. [DOI: 10.3389/ti.2022.10023] [Reference Citation Analysis]
21 Chaudhary U, Leitch KN, Chhabra A, Kohli A, Fei B. Deep Learning-Based Abdominal Muscle Segmentation on CT Images of Surgical Patient Populations. Proc SPIE Int Soc Opt Eng 2022;12036:120361N. [PMID: 36845411 DOI: 10.1117/12.2611773] [Reference Citation Analysis]
22 Sim JH, Kwon HM, Jun IG, Kim SH, Kim KS, Moon YJ, Song JG, Hwang GS. Association of skeletal muscle index with postoperative acute kidney injury in living donor hepatectomy: A retrospective single-centre cohort study. Liver Int 2022;42:425-34. [PMID: 34817911 DOI: 10.1111/liv.15109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Kimber JS, Woodman RJ, Narayana SK, John L, Ramachandran J, Schembri D, Chen JWC, Muller KR, Wigg AJ. Association of physiological reserve measures with adverse outcomes following liver transplantation. JGH Open. [DOI: 10.1002/jgh3.12702] [Reference Citation Analysis]
24 Kyrana E. Impact of Chronic Liver Disease on Nutrition, Growth and Puberty in Adolescence. In Clinical Practice 2022. [DOI: 10.1007/978-3-030-98808-1_1] [Reference Citation Analysis]
25 Anand A, Mohta S, Agarwal S, Sharma S, Gopi S, Gunjan D, Madhusudhan KS, Singh N, Saraya A. European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis. J Clin Exp Hepatol 2022;12:52-60. [PMID: 35068785 DOI: 10.1016/j.jceh.2021.03.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
26 Anand A, Nambirajan A, Kumar V, Agarwal S, Sharma S, Mohta S, Gopi S, Kaushal K, Gunjan D, Singh N, Madhusudhan KS, Chauhan SS, Sharma MC, Bansal VK, Saraya A. Alterations in Autophagy and Mammalian Target of Rapamycin (mTOR) Pathways Mediate Sarcopenia in Patients with Cirrhosis. J Clin Exp Hepatol 2022;12:510-8. [PMID: 35535114 DOI: 10.1016/j.jceh.2021.05.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Gioia S, Ridola L, Cristofaro L, Merli M, Faccioli J, Riggio O, Nardelli S. The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Liver Int 2021;41:2965-73. [PMID: 34543504 DOI: 10.1111/liv.15060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
28 El-Domiaty N, Saliba F, Karam V, Sobesky R, Ibrahim W, Vibert E, Pittau G, Amer K, Saeed MA, Shawky JA, Cherqui D, Adam R, Samuel D. Impact of body mass index on hepatocellular carcinoma recurrence after liver transplantation through long-term follow-up. Hepatobiliary Surg Nutr 2021;10:598-609. [PMID: 34760964 DOI: 10.21037/hbsn.2020.04.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Mihai F, Trifan A, Stanciu C, Huiban L, Muzîca C, Lupașcu-Ursulescu C, Negru D, Savin ML, Gîrleanu I, Cuciureanu T, Sîngeap AM. L3 Skeletal Muscle Index Dynamics in Patients with HCV-Related Compensated Cirrhosis Following Sustained Virological Response after Direct Acting Antiviral Treatment. Medicina (Kaunas) 2021;57. [PMID: 34833444 DOI: 10.3390/medicina57111226] [Reference Citation Analysis]
30 Thackeray M, Mohebbi M, Orford N, Kotowicz MA, Pasco JA. Lean mass as a risk factor for intensive care unit admission: an observational study. Crit Care 2021;25:364. [PMID: 34663393 DOI: 10.1186/s13054-021-03788-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Bonney GK, Chew CA, Lodge P, Hubbard J, Halazun KJ, Trunecka P, Muiesan P, Mirza DF, Isaac J, Laing RW, Iyer SG, Chee CE, Yong WP, Muthiah MD, Panaro F, Sanabria J, Grothey A, Moodley K, Chau I, Chan ACY, Wang CC, Menon K, Sapisochin G, Hagness M, Dueland S, Line PD, Adam R. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines. Lancet Gastroenterol Hepatol 2021;6:933-46. [PMID: 34506756 DOI: 10.1016/S2468-1253(21)00219-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
32 Boster JM, Saiman Y. Nutritional Management of Sarcopenia in Chronic Liver Disease. Curr Treat Options Gastro 2021;19:509-523. [DOI: 10.1007/s11938-021-00356-9] [Reference Citation Analysis]
33 Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 104] [Cited by in F6Publishing: 100] [Article Influence: 52.0] [Reference Citation Analysis]
34 Jitwongwai S, Lertudomphonwanit C, Junhasavasdikul T, Fuangfa P, Tanpowpong P, Gesprasert G, Treepongkaruna S. Low psoas muscle index as an unfavorable factor in children with end-stage liver disease undergoing liver transplantation. Pediatr Transplant 2021;25:e13996. [PMID: 33734542 DOI: 10.1111/petr.13996] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
35 Puchades Renau L, Herreras López J, Cebrià I Iranzo MÀ, Cezón Serrano N, Di Maira T, Berenguer M. Frailty and Sarcopenia in Acute-on-Chronic Liver Failure. Hepatol Commun 2021;5:1333-47. [PMID: 34430779 DOI: 10.1002/hep4.1722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Miarka M, Gibiński K, Janik MK, Główczyńska R, Zając K, Pacho R, Raszeja-Wyszomirska J. Sarcopenia-The Impact on Physical Capacity of Liver Transplant Patients. Life (Basel) 2021;11:740. [PMID: 34440484 DOI: 10.3390/life11080740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Erkan M, Ahmetoglu A, Cansu A, Erkut M. Evaluation of Sarcopenia and Investigation of Prognostic Value Of Sarcopenia Using Psoas Muscle Area on Computed Tomography in Patients with Liver Cirrhosis. EUROPEAN J MED ED TE 2021;14:em2111. [DOI: 10.30935/ejmets/11094] [Reference Citation Analysis]
38 Mazzola A, Brustia R, Magro B, Atif M, Ouali N, Tourret J, Barrou B, Scatton O, Conti F. Impact of sarcopenia on clinical outcomes of patients undergoing simultaneous liver and kidney transplantation: a cohort study. Clin Res Hepatol Gastroenterol 2021;45:101692. [PMID: 33848672 DOI: 10.1016/j.clinre.2021.101692] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Puneeta Tandon, Aldo J. Montano-Loza, Jennifer C. Lai, Srinivasan Dasarathy, Manuela Merli. Sarcopenia and frailty in decompensated cirrhosis. J Hepatol 2021;75. [PMID: 34039486 DOI: 10.1016/j.jhep.2021.01.025] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 29.0] [Reference Citation Analysis]
40 Cañamares-Orbis P, Bernal-Monterde V, Sierra-Gabarda O, Casas-Deza D, Garcia-Rayado G, Cortes L, Lué A. Impact of Liver and Pancreas Diseases on Nutritional Status. Nutrients 2021;13:1650. [PMID: 34068295 DOI: 10.3390/nu13051650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Woolfson JP, Perez M, Chavhan GB, Johara FT, Lurz E, Kamath BM, Ng VL. Sarcopenia in Children With End-Stage Liver Disease on the Transplant Waiting List. Liver Transpl 2021;27:641-51. [PMID: 33460522 DOI: 10.1002/lt.25985] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
42 Son SW, Song DS, Chang UI, Yang JM. Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:349. [PMID: 33923561 DOI: 10.3390/life11040349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Allen SL, Quinlan JI, Dhaliwal A, Armstrong MJ, Elsharkawy AM, Greig CA, Lord JM, Lavery GG, Breen L. Sarcopenia in chronic liver disease: mechanisms and countermeasures. Am J Physiol Gastrointest Liver Physiol 2021;320:G241-57. [PMID: 33236953 DOI: 10.1152/ajpgi.00373.2020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
44 Sciarrone SS, Zanetto A, Russo FP, Germani G, Gambato M, Battistella S, Pellone M, Shalaby S, Burra P, Senzolo M. Malnourished cirrhotic patient: what should we do? Minerva Gastroenterol (Torino) 2021;67:11-22. [PMID: 33784807 DOI: 10.23736/S2724-5985.20.02776-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Golse N, Nunez J, Mazzotta A, Cano L, Bergeat D, Sulpice L, Jeddou H, Abdelrafee A, Sa Cunha A, Cherqui D, Adam R, Boudjema K, Vibert E. Personalized Preoperative Nomograms Predicting Postoperative Risks after Resection of Perihilar Cholangiocarcinoma. World J Surg 2020;44:3449-60. [PMID: 32474628 DOI: 10.1007/s00268-020-05618-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Cheung CL, Lee GK, Au PC, Li GH, Chan M, Li HL, Cheung BM, Wong IC, Lee VH, Mok J, Yip BH, Cheng KK, Wu CH. Systematic review and meta-analysis of lean mass and mortality: Rationale and study description. Osteoporos Sarcopenia 2021;7:S3-S12. [PMID: 33997303 DOI: 10.1016/j.afos.2021.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
47 Molinari M, Jorgensen D, Ayloo S, Dharmayan S, Kaltenmeier C, Mehta RB, Jonassaint N. Preoperative Stratification of Liver Transplant Recipients: Validation of the LTRS. Transplantation 2020;104:e332-41. [PMID: 32675743 DOI: 10.1097/TP.0000000000003353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Dos Santos ALS, Anastácio LR. The impact of L-branched-chain amino acids and L-leucine on malnutrition, sarcopenia, and other outcomes in patients with chronic liver disease. Expert Rev Gastroenterol Hepatol 2021;15:181-94. [PMID: 32993404 DOI: 10.1080/17474124.2021.1829470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
49 Saiman Y, Serper M. Frailty and Sarcopenia in Patients Pre- and Post-Liver Transplant. Clin Liver Dis 2021;25:35-51. [PMID: 33978582 DOI: 10.1016/j.cld.2020.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
50 Belarmino G, Torrinhas RS, Magalhães NV, Heymsfield SB, Waitzberg DL. New anthropometric and biochemical models for estimating appendicular skeletal muscle mass in male patients with cirrhosis. Nutrition 2021;84:111083. [PMID: 33418229 DOI: 10.1016/j.nut.2020.111083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Ebadi M, Bhanji RA, Dunichand-Hoedl AR, Mazurak VC, Baracos VE, Montano-Loza AJ. Sarcopenia Severity Based on Computed Tomography Image Analysis in Patients with Cirrhosis. Nutrients. 2020;12:3463. [PMID: 33187310 DOI: 10.3390/nu12113463] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
52 Deliège PG, Braconnier A, Chaix F, Renard Y, Petrache A, Guyot-Colosio C, Kazes I, Mokri L, Barbe C, Rieu P. Skeletal Muscle Index as a Prognostic Marker for Kidney Transplantation in Older Patients. J Ren Nutr 2021;31:286-95. [PMID: 33139208 DOI: 10.1053/j.jrn.2020.08.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
53 Lindqvist C, Nordstedt P, Nowak G, Slinde F, Majeed A, Bottai M, Wahlin S. Energy expenditure early after liver transplantation: Better measured than predicted. Nutrition 2020;79-80:110817. [DOI: 10.1016/j.nut.2020.110817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, Plauth M. ESPEN practical guideline: Clinical nutrition in liver disease. Clin Nutr 2020;39:3533-62. [PMID: 33213977 DOI: 10.1016/j.clnu.2020.09.001] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 20.7] [Reference Citation Analysis]
55 Cheng TY, Lee PC, Chen YT, Chao Y, Hou MC, Huang YH. Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure. Sci Rep 2020;10:18375. [PMID: 33110117 DOI: 10.1038/s41598-020-75198-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
56 Fozouni L, Wang CW, Lai JC. Sex Differences in the Association Between Frailty and Sarcopenia in Patients With Cirrhosis. Clin Transl Gastroenterol 2019;10:e00102. [PMID: 31789932 DOI: 10.14309/ctg.0000000000000102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
57 Kappus MR, Wegermann K, Bozdogan E, Patel YA, Janas G, Shropshire E, Parish A, Niedzwiecki D, Muir AJ, Bashir M. Use of Skeletal Muscle Index as a Predictor of Wait-List Mortality in Patients With End-Stage Liver Disease. Liver Transpl 2020;26:1090-9. [PMID: 32433802 DOI: 10.1002/lt.25802] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
58 Rezende IFB, Conceição-Machado MEP, Souza VS, Santos EMD, Silva LR. Sarcopenia in children and adolescents with chronic liver disease. J Pediatr (Rio J) 2020;96:439-46. [PMID: 31005546 DOI: 10.1016/j.jped.2019.02.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
59 Rezende IFB, Conceição‐machado MEP, Souza VS, dos Santos EM, Silva LR. Sarcopenia in children and adolescents with chronic liver disease. Jornal de Pediatria (Versão em Português) 2020;96:439-46. [DOI: 10.1016/j.jpedp.2019.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
60 Rubin JB, Cullaro G, Ge J, Lai JC. Women who undergo liver transplant have longer length of stay post-transplant compared with men. Liver Int 2020;40:1725-35. [PMID: 32412164 DOI: 10.1111/liv.14512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
61 Kuo SZ, Ahmad M, Dunn MA, Montano-Loza AJ, Carey EJ, Lin S, Moghe A, Chen HW, Ebadi M, Lai JC. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation. Transplantation 2019;103:2312-7. [PMID: 30985575 DOI: 10.1097/TP.0000000000002741] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
62 Esser H, Resch T, Pamminger M, Mutschlechner B, Troppmair J, Riedmann M, Gassner E, Maglione M, Margreiter C, Boesmueller C, Oberhuber R, Weissenbacher A, Cardini B, Finkenstedt A, Zoller H, Tilg H, Öfner D, Schneeberger S. Preoperative Assessment of Muscle Mass Using Computerized Tomography Scans to Predict Outcomes Following Orthotopic Liver Transplantation. Transplantation 2019;103:2506-14. [PMID: 30985737 DOI: 10.1097/TP.0000000000002759] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
63 Salim TI, Nestlerode LC, Lucatorto EL, Wasserman TL, Din HA, Landsittel DP, Tevar AD, Johnson JT, Duarte-Rojo A, Dunn MA. Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications. Am J Gastroenterol 2020;115:859-66. [PMID: 32235146 DOI: 10.14309/ajg.0000000000000609] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
64 Al-Azzawi Y, Albo B, Fasullo M, Coukos J, Watts GJ, Tai R, Radcliffe D, Kroll-Desrosiers A, Devuni D, Szabo G. Sarcopenia is associated with longer hospital stay and multiorgan dysfunction in alcoholic hepatitis. Eur J Gastroenterol Hepatol 2020;32:733-8. [PMID: 31834050 DOI: 10.1097/MEG.0000000000001583] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
65 Pinto Dos Santos D, Kloeckner R, Koch S, Hoppe-Lotichius M, Zöller D, Toenges G, Kremer WM, Zimmermann T, Mittler J, Lang H, Düber C, Galle PR, Weinmann A, Sprinzl MF. Sarcopenia as prognostic factor for survival after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2020;32:626-34. [PMID: 31725030 DOI: 10.1097/MEG.0000000000001552] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
66 Dhaliwal A, Williams FR, El-sherif O, Armstrong MJ. Sarcopenia in Liver Transplantation: an Update. Curr Hepatology Rep 2020;19:128-37. [DOI: 10.1007/s11901-020-00515-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
67 Lurz E, Patel H, Lebovic G, Quammie C, Woolfson JP, Perez M, Ricciuto A, Wales PW, Kamath BM, Chavhan GB, Jüni P, Ng VL. Paediatric reference values for total psoas muscle area. J Cachexia Sarcopenia Muscle 2020;11:405-14. [PMID: 31920002 DOI: 10.1002/jcsm.12514] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
68 Ney M, Li S, Vandermeer B, Gramlich L, Ismond KP, Raman M, Tandon P. Systematic review with meta-analysis: Nutritional screening and assessment tools in cirrhosis. Liver Int 2020;40:664-73. [PMID: 31571398 DOI: 10.1111/liv.14269] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
69 El Sherif O, Dhaliwal A, Newsome PN, Armstrong MJ. Sarcopenia in nonalcoholic fatty liver disease: new challenges for clinical practice. Expert Rev Gastroenterol Hepatol 2020;14:197-205. [PMID: 32064966 DOI: 10.1080/17474124.2020.1731303] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
70 Cabo SN, León Díaz FJ, Segura JS, Muñoz DC, Pérez BS, Montiel Casado MC, Pérez Daga JA, Narváez JA, Fernández Aguilar JL, Suárez Muñoz MA, Santoyo JS. Influence of Preoperative Muscle Mass Assessed by Computed Tomography on Prognosis After Liver Transplantation. Transplant Proc 2020;52:537-9. [PMID: 32037067 DOI: 10.1016/j.transproceed.2020.01.001] [Reference Citation Analysis]
71 Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, Abergel A. Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice? Nutrients. 2020;12:186. [PMID: 31936597 DOI: 10.3390/nu12010186] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
72 Shenvi SD, Taber DJ, Hardie AD, Botstein JO, McGillicuddy JW. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients. HPB (Oxford) 2020;22:102-8. [PMID: 31405777 DOI: 10.1016/j.hpb.2019.06.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
73 Kumar V, Benjamin J, Shasthry V, Subramanya Bharathy KG, Sinha PK, Kumar G, Pamecha V. Sarcopenia in Cirrhosis: Fallout on Liver Transplantation. J Clin Exp Hepatol 2020;10:467-76. [PMID: 33029056 DOI: 10.1016/j.jceh.2019.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
74 Marasco G, Serenari M, Renzulli M, Alemanni LV, Rossini B, Pettinari I, Dajti E, Ravaioli F, Golfieri R, Cescon M, Festi D, Colecchia A. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments. J Gastroenterol 2020;55:927-43. [PMID: 32748172 DOI: 10.1007/s00535-020-01711-w] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 15.3] [Reference Citation Analysis]
75 Hassan A, Tapper EB. Frailty and Sarcopenia in the Critically Ill Patient with Cirrhosis. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_9] [Reference Citation Analysis]
76 Montano-loza AJ, Ebadi M. Definition and Diagnosis of Sarcopenia in the Research and Clinical Settings. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Cervantes-pérez E, Cervantes-Guevara, Cervantes-pérez L, Cervantes-pérez G, Cervantes-Cardona, Ramírez-ochoa S, Martínez-soto holguín M, González-ojeda A, Fuentes-orozco, Sosa-pérez R, Ruiz-Gallardo, Villaseñor-ochoa A, Robledo-valdez, Ramírez-casale. Estado actual del manejo nutricional en pacientes con trasplante hepático. Revista Mexicana de Trasplantes 2020;9:74-81. [DOI: 10.35366/95710] [Reference Citation Analysis]
78 Cho YH, Do KH, Chae EJ, Choi SH, Jo KW, Lee SO, Hong SB. Association of Chest CT-Based Quantitative Measures of Muscle and Fat with Post-Lung Transplant Survival and Morbidity: A Single Institutional Retrospective Cohort Study in Korean Population. Korean J Radiol 2019;20:522-30. [PMID: 30799584 DOI: 10.3348/kjr.2018.0241] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
79 Georgiou A, Papatheodoridis GV, Alexopoulou A, Deutsch M, Vlachogiannakos I, Ioannidou P, Papageorgiou MV, Papadopoulos N, Yannakoulia M, Kontogianni MD. Validation of cutoffs for skeletal muscle mass index based on computed tomography analysis against dual energy X-ray absorptiometry in patients with cirrhosis: the KIRRHOS study. Ann Gastroenterol. 2020;33:80-86. [PMID: 31892802 DOI: 10.20524/aog.2019.0432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
80 Ebadi M, Montano-Loza AJ. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis. Dig Liver Dis 2019;51:1493-9. [PMID: 31221549 DOI: 10.1016/j.dld.2019.05.034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
81 Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte-Rojo A, Dunn MA, Tsien C, Kallwitz ER, Ng V, Dasarathy S, Kappus M, Bashir MR, Montano-Loza AJ. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. Hepatology 2019;70:1816-29. [PMID: 31220351 DOI: 10.1002/hep.30828] [Cited by in Crossref: 121] [Cited by in F6Publishing: 122] [Article Influence: 30.3] [Reference Citation Analysis]
82 Nardelli S, Lattanzi B, Merli M, Farcomeni A, Gioia S, Ridola L, Riggio O. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatology 2019;70:1704-13. [PMID: 31038758 DOI: 10.1002/hep.30692] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 16.3] [Reference Citation Analysis]
83 Sinclair M. Controversies in Diagnosing Sarcopenia in Cirrhosis-Moving from Research to Clinical Practice. Nutrients. 2019;11:2454. [PMID: 31615103 DOI: 10.3390/nu11102454] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
84 Aby ES, Lee E, Saggi SS, Viramontes MR, Grotts JF, Agopian VG, Busuttil RW, Saab S. Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality. J Clin Gastroenterol 2019;53:680-5. [PMID: 30180152 DOI: 10.1097/MCG.0000000000001109] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
85 Mouzaki M, Bronsky J, Gupte G, Hojsak I, Jahnel J, Pai N, Quiros-Tejeira RE, Wieman R, Sundaram S. Nutrition Support of Children With Chronic Liver Diseases: A Joint Position Paper of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2019;69:498-511. [PMID: 31436707 DOI: 10.1097/MPG.0000000000002443] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 9.5] [Reference Citation Analysis]
86 Sinclair M, Chapman B, Hoermann R, Angus PW, Testro A, Scodellaro T, Gow PJ. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis. Liver Transpl 2019;25:1480-7. [PMID: 31282126 DOI: 10.1002/lt.25598] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 12.3] [Reference Citation Analysis]
87 Park J, Gil JR, Shin Y, Won SE, Huh J, You MW, Park HJ, Sung YS, Kim KW. Reliable and robust method for abdominal muscle mass quantification using CT/MRI: An explorative study in healthy subjects. PLoS One 2019;14:e0222042. [PMID: 31536542 DOI: 10.1371/journal.pone.0222042] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
88 Ooi PH, Hager A, Mazurak VC, Dajani K, Bhargava R, Gilmour SM, Mager DR. Sarcopenia in Chronic Liver Disease: Impact on Outcomes. Liver Transpl 2019;25:1422-38. [PMID: 31242345 DOI: 10.1002/lt.25591] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 13.5] [Reference Citation Analysis]
89 Sinclair M, Hoermann R, Peterson A, Testro A, Angus PW, Hey P, Chapman B, Gow PJ. Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk. Liver Int 2019;39:1089-97. [PMID: 30746903 DOI: 10.1111/liv.14071] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
90 Shoreibah MG, Mahmoud K, Aboueldahab NA, Vande Lune P, Massoud M, Bae S, El Khudari H, Gunn AJ, Abdel Aal AK. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts. J Vasc Interv Radiol. 2019;30:154-161. [PMID: 30717946 DOI: 10.1016/j.jvir.2018.10.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
91 Kim SS, Kim JH, Jeong WK, Lee J, Kim YK, Choi D, Lee WJ. Semiautomatic software for measurement of abdominal muscle and adipose areas using computed tomography: A STROBE-compliant article. Medicine (Baltimore) 2019;98:e15867. [PMID: 31145342 DOI: 10.1097/MD.0000000000015867] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
92 Lindqvist C, Brismar TB, Majeed A, Wahlin S. Assessment of muscle mass depletion in chronic liver disease: Dual-energy x-ray absorptiometry compared with computed tomography. Nutrition 2019;61:93-8. [DOI: 10.1016/j.nut.2018.10.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
93 Gioia S, Merli M, Nardelli S, Lattanzi B, Pitocchi F, Ridola L, Riggio O. The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS. Liver Int 2019;39:871-7. [PMID: 30667572 DOI: 10.1111/liv.14050] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
94 Jahangiri Y, Pathak P, Tomozawa Y, Li L, Schlansky BL, Farsad K. Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation: Time Course and Prognostic Implications for Survival in Cirrhosis. J Vasc Interv Radiol. 2019;30:866-872.e4. [PMID: 31053265 DOI: 10.1016/j.jvir.2019.01.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
95 Jindal A, Jagdish RK. Sarcopenia: Ammonia metabolism and hepatic encephalopathy. Clin Mol Hepatol. 2019;. [PMID: 31006226 DOI: 10.3350/cmh.2019.0015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
96 Bhanji RA, Takahashi N, Moynagh MR, Narayanan P, Angirekula M, Mara KC, Dierkhising RA, Watt KD. The evolution and impact of sarcopenia pre- and post-liver transplantation. Aliment Pharmacol Ther 2019;49:807-13. [PMID: 30714184 DOI: 10.1111/apt.15161] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
97 Mullie L, Afilalo J. CoreSlicer: a web toolkit for analytic morphomics. BMC Med Imaging 2019;19:15. [PMID: 30744586 DOI: 10.1186/s12880-019-0316-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
98 Acosta LF, Galuppo R, García CR, Villacorta E, Dugan A, Castellanos AL, Gedaly R, Lee JT. Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. J Surg Res 2019;238:10-5. [PMID: 30721781 DOI: 10.1016/j.jss.2019.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
99 Stam SP, Osté MCJ, Eisenga MF, Blokzijl H, van den Berg AP, Bakker SJL, de Meijer VE. Posttransplant muscle mass measured by urinary creatinine excretion rate predicts long-term outcomes after liver transplantation. Am J Transplant 2019;19:540-50. [PMID: 29745020 DOI: 10.1111/ajt.14926] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
100 Idriss R, Hasse J, Wu T, Khan F, Saracino G, McKenna G, Testa G, Trotter J, Klintmalm G, Asrani SK. Impact of Prior Bariatric Surgery on Perioperative Liver Transplant Outcomes. Liver Transpl 2019;25:217-27. [PMID: 30369002 DOI: 10.1002/lt.25368] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
101 Montgomery J, Englesbe M. Sarcopenia in Liver Transplantation. Curr Transplant Rep 2019;6:7-15. [PMID: 31595213 DOI: 10.1007/s40472-019-0223-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
102 Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, Bischoff SC. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr 2019;38:485-521. [PMID: 30712783 DOI: 10.1016/j.clnu.2018.12.022] [Cited by in Crossref: 237] [Cited by in F6Publishing: 250] [Article Influence: 59.3] [Reference Citation Analysis]
103 Ebadi M, Bhanji RA, Mazurak VC, Montano-Loza AJ. Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol 2019;54:845-59. [PMID: 31392488 DOI: 10.1007/s00535-019-01605-6] [Cited by in Crossref: 102] [Cited by in F6Publishing: 108] [Article Influence: 25.5] [Reference Citation Analysis]
104 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol 2019;70:172-93. [PMID: 30144956 DOI: 10.1016/j.jhep.2018.06.024] [Cited by in Crossref: 394] [Cited by in F6Publishing: 395] [Article Influence: 98.5] [Reference Citation Analysis]
105 Jeong JY, Lim S, Sohn JH, Lee JG, Jun DW, Kim Y. Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis. J Korean Med Sci 2018;33:e299. [PMID: 30534029 DOI: 10.3346/jkms.2018.33.e299] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
106 Hsu CS, Kao JH. Sarcopenia and chronic liver diseases. Expert Rev Gastroenterol Hepatol 2018;12:1229-44. [PMID: 30791794 DOI: 10.1080/17474124.2018.1534586] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 9.4] [Reference Citation Analysis]
107 Tandon P, Ismond KP, Riess K, Duarte-Rojo A, Al-Judaibi B, Dunn MA, Holman J, Howes N, Haykowsky MJF, Josbeno DA, McNeely M. Exercise in cirrhosis: Translating evidence and experience to practice. J Hepatol 2018;69:1164-77. [PMID: 29964066 DOI: 10.1016/j.jhep.2018.06.017] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 19.0] [Reference Citation Analysis]
108 Stirnimann G, Ebadi M, Tandon P, Montano-Loza AJ. Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication? Curr Gastroenterol Rep. 2018;20:50. [PMID: 30259203 DOI: 10.1007/s11894-018-0656-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
109 Merli M, Durand F. Muscle mass vs. adipose tissue to predict outcome in cirrhosis: Which matters and in which patients? J Hepatol 2018;69:567-9. [PMID: 30122221 DOI: 10.1016/j.jhep.2018.06.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
110 Ebadi M, Tandon P, Moctezuma-Velazquez C, Ghosh S, Baracos VE, Mazurak VC, Montano-Loza AJ. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis. J Hepatol 2018;69:608-16. [PMID: 29709682 DOI: 10.1016/j.jhep.2018.04.015] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 15.6] [Reference Citation Analysis]
111 Mager DR, Hager A, Ooi PH, Siminoski K, Gilmour SM, Yap JY. Persistence of Sarcopenia After Pediatric Liver Transplantation Is Associated With Poorer Growth and Recurrent Hospital Admissions. Journal of Parenteral and Enteral Nutrition 2019;43:271-80. [DOI: 10.1002/jpen.1414] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
112 Chang CD, Wu JS, Mhuircheartaigh JN, Hochman MG, Rodriguez EK, Appleton PT, Mcmahon CJ. Effect of sarcopenia on clinical and surgical outcome in elderly patients with proximal femur fractures. Skeletal Radiol 2018;47:771-7. [PMID: 29247259 DOI: 10.1007/s00256-017-2848-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
113 Lattanzi B, D’ambrosio D, Fedele V, Merli M. Nutritional Assessment and Management for Hospitalized Patients with Cirrhosis. Curr Hepatology Rep 2018;17:88-96. [DOI: 10.1007/s11901-018-0398-6] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
114 Gu DH, Kim MY, Seo YS, Kim SG, Lee HA, Kim TH, Jung YK, Kandemir A, Kim JH, An H, Yim HJ, Yeon JE, Byun KS, Um SH. Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis. Clin Mol Hepatol. 2018;24:319-330. [PMID: 29706058 DOI: 10.3350/cmh.2017.0077] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 11.2] [Reference Citation Analysis]
115 Fuchs G, Thevathasan T, Chretien YR, Mario J, Piriyapatsom A, Schmidt U, Eikermann M, Fintelmann FJ. Lumbar skeletal muscle index derived from routine computed tomography exams predict adverse post-extubation outcomes in critically ill patients. Journal of Critical Care 2018;44:117-23. [DOI: 10.1016/j.jcrc.2017.10.033] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
116 Praktiknjo M, Book M, Luetkens J, Pohlmann A, Meyer C, Thomas D, Jansen C, Feist A, Chang J, Grimm J, Lehmann J, Strassburg CP, Abraldes JG, Kukuk G, Trebicka J. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology 2018;67:1014-26. [PMID: 29059469 DOI: 10.1002/hep.29602] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 18.0] [Reference Citation Analysis]
117 Lurz E, Patel H, Frimpong RG, Ricciuto A, Kehar M, Wales PW, Towbin AJ, Chavhan GB, Kamath BM, Ng VL. Sarcopenia in Children With End-Stage Liver Disease. J Pediatr Gastroenterol Nutr 2018;66:222-6. [PMID: 29356766 DOI: 10.1097/MPG.0000000000001792] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 10.0] [Reference Citation Analysis]
118 Irlbeck T, Janitza S, Poros B, Golebiewski M, Frey L, Paprottka PM, da Silva T, Irlbeck M, Böcker W, Weig T. Quantification of Adipose Tissue and Muscle Mass Based on Computed Tomography Scans: Comparison of Eight Planimetric and Diametric Techniques Including a Step-By-Step Guide. Eur Surg Res 2018;59:23-34. [PMID: 29393202 DOI: 10.1159/000486173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
119 Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl 2018;24:122-39. [PMID: 29024353 DOI: 10.1002/lt.24958] [Cited by in Crossref: 105] [Cited by in F6Publishing: 105] [Article Influence: 21.0] [Reference Citation Analysis]
120 Mathew A, Halegoua-De Marzio D, Reddy S, Wong SY, Cheung M, Mosca H, Guglielmo F, Halpern E, Sass DA, Doria C. Pre-Liver Transplant Muscle Loss Is a Risk Factor for Post-Liver Transplantation Left Ventricular Systolic Dysfunction. Ann Transplant 2017;22:759-64. [PMID: 29269723 DOI: 10.12659/aot.905610] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
121 Anand AC. Nutrition and Muscle in Cirrhosis. J Clin Exp Hepatol 2017;7:340-57. [PMID: 29234200 DOI: 10.1016/j.jceh.2017.11.001] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 12.8] [Reference Citation Analysis]
122 Haafiz AB. A mechanism based approach to management of children with end-stage liver disease. Expert Rev Gastroenterol Hepatol 2017;11:1085-94. [PMID: 28803487 DOI: 10.1080/17474124.2017.1367662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Mazurak VC, Tandon P, Montano-Loza AJ. Nutrition and the transplant candidate. Liver Transpl 2017;23:1451-64. [PMID: 29072825 DOI: 10.1002/lt.24848] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
124 Benjamin J, Shasthry V, Kaal CR, Anand L, Bhardwaj A, Pandit V, Arora A, Rajesh S, Pamecha V, Jain V, Kumar G, Loria A, Puri P, Joshi YK, Sarin SK. Characterization of body composition and definition of sarcopenia in patients with alcoholic cirrhosis: A computed tomography based study. Liver Int 2017;37:1668-74. [PMID: 29065258 DOI: 10.1111/liv.13509] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
125 Kim G, Kang SH, Kim MY, Baik SK. Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. PLoS One. 2017;12:e0186990. [PMID: 29065187 DOI: 10.1371/journal.pone.0186990] [Cited by in Crossref: 149] [Cited by in F6Publishing: 170] [Article Influence: 24.8] [Reference Citation Analysis]
126 Sundaram V, Lim J, Tholey DM, Iriana S, Kim I, Manne V, Nissen NN, Klein AS, Tran TT, Ayoub WS, Schlansky B. The Braden Scale, A standard tool for assessing pressure ulcer risk, predicts early outcomes after liver transplantation. Liver Transpl 2017;23:1153-60. [PMID: 28512923 DOI: 10.1002/lt.24789] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
127 Grochocinski A, Dandalides A, Remley L. Nutrition for the Patient with Advanced Liver Disease. Curr Hepatology Rep 2017;16:205-211. [DOI: 10.1007/s11901-017-0354-x] [Reference Citation Analysis]
128 Halliday N, Westbrook RH. Liver transplantation: need, indications, patient selection and pre-transplant care. Br J Hosp Med (Lond) 2017;78:252-9. [PMID: 28489446 DOI: 10.12968/hmed.2017.78.5.252] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
129 Mcclellan T, Allen BC, Kappus M, Bhatti L, Dafalla RA, Snyder LD, Bashir MR. Repeatability of Computerized Tomography–Based Anthropomorphic Measurements of Frailty in Patients With Pulmonary Fibrosis Undergoing Lung Transplantation. Current Problems in Diagnostic Radiology 2017;46:300-4. [DOI: 10.1067/j.cpradiol.2016.12.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
130 Chang SH, Liu X, Carlsson NP, Park Y, Colditz GA, Garonzik-Wang JM, Chapman WC, Wellen JR, Doyle MB, Alhamad T. Reexamining the Association of Body Mass Index With Overall Survival Outcomes After Liver Transplantation. Transplant Direct 2017;3:e172. [PMID: 28706975 DOI: 10.1097/TXD.0000000000000681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
131 Carey EJ, Lai JC, Wang CW, Dasarathy S, Lobach I, Montano-Loza AJ, Dunn MA; Fitness, Life Enhancement, and Exercise in Liver Transplantation Consortium. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl 2017;23:625-33. [PMID: 28240805 DOI: 10.1002/lt.24750] [Cited by in Crossref: 263] [Cited by in F6Publishing: 262] [Article Influence: 43.8] [Reference Citation Analysis]
132 Belarmino G, Gonzalez MC, Sala P, Torrinhas RS, Andraus W, D’albuquerque LAC, Pereira RMR, Caparbo VF, Ferrioli E, Pfrimer K, Damiani L, Heymsfield SB, Waitzberg DL. Diagnosing Sarcopenia in Male Patients With Cirrhosis by Dual-Energy X-Ray Absorptiometry Estimates of Appendicular Skeletal Muscle Mass. JPEN J Parenter Enteral Nutr 2017. [DOI: 10.1177/0148607117701400] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
133 Golse N, Bucur PO, Ciacio O, Pittau G, Sa Cunha A, Adam R, Castaing D, Antonini T, Coilly A, Samuel D, Cherqui D, Vibert E. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation. Liver Transpl 2017;23:143-54. [PMID: 28061014 DOI: 10.1002/lt.24671] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 16.8] [Reference Citation Analysis]
134 Nawaz H, Chopra K. Preoperative Liver Recipient Evaluation and Preparation. Anesthesia and Perioperative Care for Organ Transplantation 2017. [DOI: 10.1007/978-1-4939-6377-5_26] [Reference Citation Analysis]
135 Dunn MA, Josbeno DA, Tevar AD, Rachakonda V, Ganesh SR, Schmotzer AR, Kallenborn EA, Behari J, Landsittel DP, DiMartini AF, Delitto A. Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization. Am J Gastroenterol 2016;111:1768-75. [PMID: 27575708 DOI: 10.1038/ajg.2016.336] [Cited by in Crossref: 91] [Cited by in F6Publishing: 81] [Article Influence: 13.0] [Reference Citation Analysis]
136 Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol 2016;65:1232-44. [PMID: 27515775 DOI: 10.1016/j.jhep.2016.07.040] [Cited by in Crossref: 326] [Cited by in F6Publishing: 330] [Article Influence: 46.6] [Reference Citation Analysis]
137 Lindqvist C, Majeed A, Wahlin S. Body composition assessed by dual-energy X-ray absorptiometry predicts early infectious complications after liver transplantation. J Hum Nutr Diet 2017;30:284-91. [PMID: 27709718 DOI: 10.1111/jhn.12417] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
138 Dunn MA, Josbeno DA, Schmotzer AR, Tevar AD, DiMartini AF, Landsittel DP, Delitto A. The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates. Liver Transpl 2016;22:1324-32. [PMID: 27348200 DOI: 10.1002/lt.24506] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 8.6] [Reference Citation Analysis]
139 Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res 2016;46:951-63. [PMID: 27481650 DOI: 10.1111/hepr.12774] [Cited by in Crossref: 302] [Cited by in F6Publishing: 337] [Article Influence: 43.1] [Reference Citation Analysis]
140 van Vugt JL, Levolger S, de Bruin RW, van Rosmalen J, Metselaar HJ, IJzermans JN. Systematic Review and Meta-Analysis of the Impact of Computed Tomography-Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation. Am J Transplant 2016;16:2277-92. [PMID: 26813115 DOI: 10.1111/ajt.13732] [Cited by in Crossref: 218] [Cited by in F6Publishing: 212] [Article Influence: 31.1] [Reference Citation Analysis]
141 Sinelnikov A, Qu C, Fetzer DT, Pelletier JS, Dunn MA, Tsung A, Furlan A. Measurement of skeletal muscle area: Comparison of CT and MR imaging. Eur J Radiol 2016;85:1716-21. [PMID: 27666607 DOI: 10.1016/j.ejrad.2016.07.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
142 Kappus MR, Mendoza MS, Nguyen D, Medici V, Mcclave SA. Sarcopenia in Patients with Chronic Liver Disease: Can It Be Altered by Diet and Exercise? Curr Gastroenterol Rep 2016;18. [DOI: 10.1007/s11894-016-0516-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
143 Thandassery RB, Montano-Loza AJ. Role of Nutrition and Muscle in Cirrhosis. Curr Treat Options Gastroenterol. 2016;14:257-273. [PMID: 27023701 DOI: 10.1007/s11938-016-0093-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
144 Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther 2016;43:765-77. [PMID: 26847265 DOI: 10.1111/apt.13549] [Cited by in Crossref: 195] [Cited by in F6Publishing: 178] [Article Influence: 27.9] [Reference Citation Analysis]
145 Sinclair M, Grossmann M, Angus PW, Hoermann R, Hey P, Scodellaro T, Gow PJ. Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease. J Gastroenterol Hepatol 2016;31:661-7. [PMID: 26414812 DOI: 10.1111/jgh.13182] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
146 Anastácio LR, Davisson Correia MIT. Nutrition therapy: Integral part of liver transplant care. World J Gastroenterol 2016; 22(4): 1513-1522 [PMID: 26819518 DOI: 10.3748/wjg.v22.i4.1513] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
147 Singer P, Cohen J. Severe Undernutrition. The Stress Response of Critical Illness: Metabolic and Hormonal Aspects 2016. [DOI: 10.1007/978-3-319-27687-8_15] [Reference Citation Analysis]
148 Plank LD, Russell K. Nutrition in liver transplantation: too little or too much? Curr Opin Clin Nutr Metab Care 2015;18:501-7. [PMID: 26164328 DOI: 10.1097/MCO.0000000000000205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
149 Kim HY, Jang JW. Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score. World J Gastroenterol 2015; 21(25): 7637-7647 [PMID: 26167066 DOI: 10.3748/wjg.v21.i25.7637] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 75] [Article Influence: 9.1] [Reference Citation Analysis]
150 Darstein F, König C, Hoppe-lotichius M, Grimm D, Knapstein J, Zimmermann A, Mittler J, Schattenberg J, Sprinzl M, Wörns M, Lang H, Galle P, Zimmermann T. New onset of diabetes after transplantation is associated with improved patient survival after liver transplantation due to confounding factor. European Journal of Internal Medicine 2015;26:439-44. [DOI: 10.1016/j.ejim.2015.05.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
151 Diaz G, Levitsky J, Oniscu G. Meeting report of the 2014 joint international congress of the International Liver Transplantation Society, Liver Intensive Care Group of Europe, and European Liver and Intestinal Association. Liver Transpl 2015;21:991-1000. [PMID: 25857840 DOI: 10.1002/lt.24144] [Reference Citation Analysis]
152 Sarkar M, Watt KD, Terrault N, Berenguer M. Outcomes in liver transplantation: does sex matter? J Hepatol 2015;62:946-55. [PMID: 25433162 DOI: 10.1016/j.jhep.2014.11.023] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 7.8] [Reference Citation Analysis]
153 Giusto M, Lattanzi B, Albanese C, Galtieri A, Farcomeni A, Giannelli V, Lucidi C, Di Martino M, Catalano C, Merli M. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry. Eur J Gastroenterol Hepatol 2015;27:328-34. [PMID: 25569567 DOI: 10.1097/MEG.0000000000000274] [Cited by in Crossref: 128] [Cited by in F6Publishing: 117] [Article Influence: 16.0] [Reference Citation Analysis]
154 Bergerson JT, Lee JG, Furlan A, Sourianarayanane A, Fetzer DT, Tevar AD, Landsittel DP, DiMartini AF, Dunn MA. Liver transplantation arrests and reverses muscle wasting. Clin Transplant. 2015;29:216-221. [PMID: 25557648 DOI: 10.1111/ctr.12506] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
155 Yadav A, Chang YH, Carpenter S, Silva AC, Rakela J, Aqel BA, Byrne TJ, Douglas DD, Vargas HE, Carey EJ. Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transplant. 2015;29:134-141. [PMID: 25430554 DOI: 10.1111/ctr.12493] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 10.8] [Reference Citation Analysis]
156 Rodríguez-Castro KI, De Martin E, Gambato M, Lazzaro S, Villa E, Burra P. Female gender in the setting of liver transplantation. World J Transplant 2014; 4(4): 229-242 [PMID: 25540733 DOI: 10.5500/wjt.v4.i4.229] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
157 Sinclair M, Angus PW, Grossmann M, Gow PJ. Muscle mass and mortality in chronic liver disease: the impact of testosterone. Liver Transpl 2014;20:504-5. [PMID: 24357579 DOI: 10.1002/lt.23808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Dimartini A, Dew MA. Reply: To PMID 23960026. Liver Transpl 2014;20:506. [PMID: 24493143 DOI: 10.1002/lt.23842] [Reference Citation Analysis]
159 Watt KD. Obesity evolution or revolution: there is more to it than meets the BMI. Liver Transpl 2014;20:253-4. [PMID: 24470214 DOI: 10.1002/lt.23809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]